SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 98.47 |
| Enterprise Value ($M) | 96.16 |
| Book Value ($M) | 20.69 |
| Book Value / Share | 0.64 |
| Price / Book | 4.76 |
| NCAV ($M) | 20.45 |
| NCAV / Share | 0.64 |
| Price / NCAV | 4.81 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.59 |
| Return on Assets (ROA) | -0.48 |
| Return on Equity (ROE) | -0.53 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 11.31 |
| Current Ratio | 11.31 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 22.67 |
| Assets | 22.91 |
| Liabilities | 2.22 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Catelani Michael | 5.25 | ||
| 13D/A | Kumar Amit | 13.50 | 42.70 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 64,593 | 588,823 | 10.97 | |
| 3,662 | 26,129 | 14.02 | |
| 3,804 | 30,292 | 12.56 | |
| 11,879 | 50,988 | 23.30 | |
| 15,309 | 85,733 | 17.86 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ALVR – AlloVir, Inc. | ALZN – Alzamend Neuro, Inc. |
| ANEB – Anebulo Pharmaceuticals, Inc. | APM – Aptorum Group Limited |
| APRE – Aprea Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io